Codice QR

A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice.

A genetically engineered fusion protein consisting of a human/mouse chimeric anti-ganglioside GD2 antibody (ch14.18) and recombinant human interleukin 2 (rhIL-2) was tested for its ability to target rhIL-2 to tumor sites and stimulate immune effector cells sufficiently to achieve effective tumor cel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Proc Natl Acad Sci U S A
Autori principali: Sabzevari, H, Gillies, S D, Mueller, B M, Pancook, J D, Reisfeld, R A
Natura: Artigo
Lingua:Inglês
Pubblicazione: National Academy of Sciences 1994
Soggetti:
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC44866/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7937818/
https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.91.20.9626
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!